GoodRx Holdings Inc. (NASDAQ:GDRX) saw an upside of 5.46% to $42.85 after adding $2.22 on Wednesday. The 5-day average trading volume is 1,039,601 shares of the company’s common stock. It has gained $45.19 in the past week. An average of 1,567,155 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,743,660.
GDRX’s 1-month performance is -8.12% or -$1.08 on its low of $39.44 reached on 09/29/21. The company’s shares have touched a 52-week low of $26.66 and high of $59.67, with the stock’s rally to the 52-week high happening on 02/10/21. YTD, GDRX has achieved 0.72% or $2.80. However, the current price is down -28.19%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Oct 07, 6 days have gone by since the last insider trading activity for GoodRx Holdings Inc. (GDRX). NAGJI BANSI (President, Healthcare) most recently sold 3,600 shares at $45.05 per share on Oct 07. This transaction cost the insider $162,187. President, Consumer, Slutsky Andrew, sold 35,018 shares at a price of $43.03 on Oct 01. Then, on Sep 30, 10% Owner Idea Men, LLC sold 167,557 shares at a price of $41.08 per share. This transaction amounted to $6,882,624.
GoodRx Holdings Inc. (GDRX) has a trailing price-to-earnings (P/E) ratio of 23.70 for the broader industry and 32.19 for the sector. The company’s PE ratio for the last five years has touched a high of 451.64 and a low of 371.40. GDRX stock has a beta of 0.00. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 26.53 while the price-to-book (PB) in the most recent quarter is 20.11, with the price to cash flow ratio at 157.82.
GoodRx Holdings Inc.’s quick ratio for the period ended June 29 was 16.40, with the current ratio over the same period at 16.40 meaning that GDRX stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.80, while the total debt to equity was 0.81. In terms of profitability, the gross margin trailing 12 months is 93.90%. The trailing 12-month EBITDA margin is -44.40% while for the period ending June 29; GoodRx Holdings Inc.’s operating margin was -58.10%. The firm’s gross profit as reported stood at $521.11 million against revenue of $550.7 million.
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Analysts expected GDRX to announce $0.08 per share in earnings in its latest quarter, but it posted $0.08, representing a 0.00% surprise. EBITDA for the quarter stood at more than $8.88 million. GDRX stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 762.53 million, with total debt at $704.05 million. Shareholders hold equity totaling $395.64 million
Let’s look briefly at GoodRx Holdings Inc. (GDRX) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 54.80% to suggest the stock is trending Neutral, with historical volatility in this time period at 71.34%.
The stock’s 5-day moving average is $41.50, reflecting a +0.56% or $0.24 change from its current price. GDRX is currently trading -2.60% above its 20-day SMA, +39.88% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by +36.35% and -1.01% respectively.
Stochastic %K and %D was 29.12% and 22.05% and the average true range (ATR) pointed at 2.43. The RSI (14) points at 54.41%, while the 14-day stochastic is at 53.47% with the period’s ATR at 2.37. The stock’s 9-day MACD Oscillator is pointing at -0.47 and -0.38 on the 14-day charts.
In the most recent analyst report for GoodRx Holdings Inc. (NASDAQ: GDRX), Barclays upgraded it to an Overweight rating. They previously had an Equal weight rating on the stock. Analysts offering their rating for GDRX stock have a consensus rating for the stock as Overweight. Currently, 1 brokerage advisors rate GDRX as a “sell,”, while 5 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 2 rates the stock as overweight while 7 have offered a “buy” rating.
What is GDRX’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $28.00 and a high of $56.00, with their median price target at $43.50. Looking at these predictions, the average price target given by analysts is for GoodRx Holdings Inc. (GDRX) stock is $43.79.